Idiopathic Pulmonary Haemosiderosis; Factors That Effect Prognosis

M. Gharibzadeh Hizal (Ankara, Turkey), S. Eryilmaz Polat (Ankara, Turkey), T. Ramasli Gursoy (Ankara, Turkey), D. Ademhan Tural (Ankara, Turkey), B. Ozesen (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), S. Pekcan (Ankara, Turkey), A. Tana Aslan (Ankara, Turkey), E. Yalcin (Ankara, Turkey), D. Dogru (Ankara, Turkey), U. Ozcelik (Ankara, Turkey), N. Kiper (Ankara, Turkey)

Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Session: Tip the hat to paediatric bronchology
Session type: Oral Presentation
Number: 5290

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Gharibzadeh Hizal (Ankara, Turkey), S. Eryilmaz Polat (Ankara, Turkey), T. Ramasli Gursoy (Ankara, Turkey), D. Ademhan Tural (Ankara, Turkey), B. Ozesen (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), S. Pekcan (Ankara, Turkey), A. Tana Aslan (Ankara, Turkey), E. Yalcin (Ankara, Turkey), D. Dogru (Ankara, Turkey), U. Ozcelik (Ankara, Turkey), N. Kiper (Ankara, Turkey). Idiopathic Pulmonary Haemosiderosis; Factors That Effect Prognosis. 5290

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015

Impact of depression on patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014

Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study)
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021



Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Prognostic Factors for Mortality in Chronic Pulmonary Aspergillosis -Experience in Japan-
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021


Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Predictors of Progression in Patients with Pulmonary Sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020


Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014


Prognosis factors of recurrent pulmonary thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – M-health/e-health I
Year: 2019


Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020


The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019